Ipsen Acquires Memo Therapeutics to Expand Rare Disease Pipeline
PARIS, France & SCHLIEREN/ZURICH, Switzerland, July 1, 2026 Ipsen has announced a definitive agreement to acquire Memo Therapeutics AG,...
Biopharmaceutical Acquisition
Advertisement
Zymeworks Acquires Theravance to Expand Healthcare Portfolio
VANCOUVER, British Columbia, June 29, 2026 Zymeworks Inc. has announced a definitive agreement to acquire Theravance Biopharma, Inc. in...
Ipsen and Kartos Therapeutics Sign $1.75B Acquisition Deal
PARIS, France & REDWOOD CITY, Calif., June 29, 2026 Ipsen has announced a definitive agreement to acquire Kartos Therapeutics,...
Samsung Bioepis Reports Positive SB27 Keytruda Biosimilar Results
INCHEON, South Korea, June 29, 2026 Samsung Bioepis Co., Ltd. has announced positive preliminary results from both its Phase...
Advertisement
